VARIVAX 1350 [PFU]/.5mL
Varicella Virus Vaccine Live · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Merck Sharp & Dohme LLC
VARIVAX is a injection, powder, lyophilized, for suspension containing varicella virus vaccine live at 1350 [PFU]/.5mL, taken subcutaneous. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- VARIVAX
- Generic Name
- Varicella Virus Vaccine Live
- NDC Code (Product)
0006-4827- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 1350 [PFU]/.5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103552
- Marketing Start
- 03/17/1995
Recall History
No Recall HistoryFrequently Asked Questions
What is VARIVAX used for?
VARIVAX contains Varicella Virus Vaccine Live. It is a injection, powder, lyophilized, for suspension taken subcutaneous. Consult your doctor for specific uses.
Is VARIVAX a controlled substance?
VARIVAX is not classified as a controlled substance by the DEA.
What is the generic name for VARIVAX?
The generic name for VARIVAX is Varicella Virus Vaccine Live. There are no other listed brand versions of Varicella Virus Vaccine Live.
What is the NDC code for VARIVAX 1350 [PFU]/.5mL?
The NDC (National Drug Code) for VARIVAX 1350 [PFU]/.5mL is 0006-4827, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)